Company Analysis Carl Zeiss Meditec AG
1. Summary
Advantages
- Price (59.3 $) is less than fair price (76.56 $)
Disadvantages
- Dividends (0%) are below the sector average (2.68%).
- The stock's return over the last year (-29.84%) is lower than the sector average (-5.06%).
- The company's current efficiency (ROE=0%) is lower than the sector average (ROE=7.61%)
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Carl Zeiss Meditec AG | Healthcare | Index | |
|---|---|---|---|
| 7 days | 6.4% | -1.3% | 0.4% |
| 90 days | -8.2% | -2.8% | 8% |
| 1 year | -29.8% | -5.1% | 28.4% |
AFX vs Sector: Carl Zeiss Meditec AG has significantly underperformed the "Healthcare" sector by -24.78% over the past year.
AFX vs Market: Carl Zeiss Meditec AG has significantly underperformed the market by -58.22% over the past year.
Stable price: AFX is not significantly more volatile than the rest of the market on "Stuttgart Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: AFX with weekly volatility of -0.5738% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (59.3 $) is lower than the fair price (76.56 $).
Price significantly below the fair price: The current price (59.3 $) is 29.1% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (89.51).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (52.97).
4.3. P/BV
P/BV vs Sector: The company's P/BV (0) is lower than that of the sector as a whole (7.16).
P/BV vs Market: The company's P/BV (0) is lower than that of the market as a whole (4.62).
4.4. P/S
P/S vs Sector: The company's P/S indicator (0) is lower than that of the sector as a whole (4.76).
P/S vs Market: The company's P/S indicator (0) is lower than that of the market as a whole (3.04).
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (0) is lower than that of the sector as a whole (30.3).
EV/Ebitda vs Market: The company's EV/Ebitda (0) is lower than that of the market as a whole (20.77).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -20% over the last 5 years.
Earnings Slowdown: The last year's return (-100%) is below the 5-year average return (-20%).
Profitability vs Sector: The return for the last year (-100%) is lower than the return for the sector (10.13%).
5.4. ROE
ROE vs Sector: The company's ROE (0%) is lower than that of the sector as a whole (7.61%).
ROE vs Market: The company's ROE (0%) is lower than that of the market as a whole (10.62%).
5.5. ROA
ROA vs Sector: The company's ROA (0%) is lower than that of the sector as a whole (5.12%).
ROA vs Market: The company's ROA (0%) is lower than that of the market as a whole (4.08%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '2.68%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0% has been steadily paid over the past 7 years, DSI=0.93.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 2 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
